JD HEALTH

06618
Share your thoughts

What's on your mind?

0 / 2,000
19.6k followers · 0 opinions
▲Bullish50%
50%Bearish▼
  • F
    Fattycat
    Featured

    $JD.com(JD.US)$JD-SW(09618.HK)

    🚀 JD.com Unleashes “Physical AI” - The 5-Year Plan That Will Change Everything!

    JD.com shares closed at HK$105.500 with a slight dip recently. But look past that short-term move and you will see a massive five-year vision taking shape.

    JD is moving beyond software and right into the real world with an ambitious Physical AI acceleration plan.

    🤖 Massive Automation

    JD Logistics plans to deploy 3 million robots plus 1 million unmanned vehicles and 100,000 drones.

    🏢 New Infrastructure

    The company will build 80 RoboBase industrial bases across the country.

    📱 AI-Powered Shopping

    The new App Version 16.0 introduces Dongdong. This AI assistant helps with everything from product selection to arranging housekeeping services.

    🩺 Smart Healthcare

    JD Health has unveiled a fully intelligent medical AI agent that connects users with consultations and home testing services.

    From warehouse floors to your smartphone, JD.com is going all in on a hardware-heavy AI future.

    Check out the latest infographic for the full picture of this strategic shift!

    Not financial advice. Do your own DD☺️.

    图片 1,共 2 张
    < 09618JD-SW Closed 09.1016:08:44 123.6k Quotes Overview Financials 105.500 -0.8
  • P
    Profit

    Zai Lab's commercialization and licensing model in China has seen multiple products included in the national reimbursement drug list (NRDL), with high visibility for revenue growth in 2026.

    JD Health, a leader in internet healthcare, continues to see growth in monthly active users and online penetration of prescription drugs. Improved consumer sentiment post-ceasefire is beneficial for platform transaction volume.

    Insilico Medicine is a globally representative company in AI-driven drug discovery, with pipeline progress being a short-term catalyst. Its latest funding round valued the company at over $600 million, and it is currently in a window of valuation re-rating as it transitions from an AI tool provider to a clinical-stage pipeline company.

  • M
    momoM

    $XTALPI(02228.HK) Goldman Sachs launched the "China AI Healthcare Index" today, with Pharmaron as the top-weighted stock $ALI HEALTH(00241.HK)$JD HEALTH(06618.HK)$PA GOODDOCTOR(01833.HK)$YIDU TECH(02158.HK)$MircroPort Medbot-B(02252.HK)

    图片 1,共 1 张